506 related articles for article (PubMed ID: 11753687)
1. A novel human cancer culture model for the study of prostate cancer.
Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
[TBL] [Abstract][Full Text] [Related]
2. A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.
Gu Y; Kim KH; Ko D; Nakamura K; Yasunaga Y; Moul JW; Srivastava S; Arnstein P; Rhim JS
Int J Oncol; 2004 Oct; 25(4):1057-64. PubMed ID: 15375556
[TBL] [Abstract][Full Text] [Related]
3. A novel human cell culture model for the study of familial prostate cancer.
Yasunaga Y; Nakamura K; Ewing CM; Isaacs WB; Hukku B; Rhim JS
Cancer Res; 2001 Aug; 61(16):5969-73. PubMed ID: 11507036
[TBL] [Abstract][Full Text] [Related]
4. A novel neoplastic primary tumor-derived human prostate epithelial cell line.
Ko D; Gu Y; Yasunaga Y; Nakamura K; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Arnstein P; Taylor DO; Hukku B; Rhim JS
Int J Oncol; 2003 Jun; 22(6):1311-7. PubMed ID: 12738999
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase.
Kim KH; Dobi A; Shaheduzzaman S; Gao CL; Masuda K; Li H; Drukier A; Gu Y; Srikantan V; Rhim JS; Srivastava S
Prostate Cancer Prostatic Dis; 2007; 10(1):30-8. PubMed ID: 17075604
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
Gu Y; Li H; Miki J; Kim KH; Furusato B; Sesterhenn IA; Chu WS; McLeod DG; Srivastava S; Ewing CM; Isaacs WB; Rhim JS
Exp Cell Res; 2006 Apr; 312(6):831-43. PubMed ID: 16413016
[TBL] [Abstract][Full Text] [Related]
7. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.
Kuzmin I; Gillespie JW; Protopopov A; Geil L; Dreijerink K; Yang Y; Vocke CD; Duh FM; Zabarovsky E; Minna JD; Rhim JS; Emmert-Buck MR; Linehan WM; Lerman MI
Cancer Res; 2002 Jun; 62(12):3498-502. PubMed ID: 12067994
[TBL] [Abstract][Full Text] [Related]
8. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
[TBL] [Abstract][Full Text] [Related]
10. Androgen and androgen receptor antagonist responsive primary African-American benign prostate epithelial cell line.
Gu Y; Kim KH; Ko D; Srivastava S; Moul JW; McLeod DG; Rhim JS
Anticancer Res; 2005; 25(1A):1-8. PubMed ID: 15816512
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
12. Cadmium-induced neoplastic transformation of human prostate epithelial cells.
Nakamura K; Yasunaga Y; Ko D; Xu LL; Moul JW; Peehl DM; Srivastava S; Rhim JS
Int J Oncol; 2002 Mar; 20(3):543-7. PubMed ID: 11836566
[TBL] [Abstract][Full Text] [Related]
13. Telomerase prolongs the lifespan of normal human ovarian surface epithelial cells without inducing neoplastic phenotype.
Alvero AB; Fishman DA; Qumsiyeh MB; Garg M; Kacinski BM; Sapi E
J Soc Gynecol Investig; 2004 Dec; 11(8):553-61. PubMed ID: 15582501
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
Song K; Cornelius SC; Danielpour D
Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
[TBL] [Abstract][Full Text] [Related]
15. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
Li H; Zhou J; Miki J; Furusato B; Gu Y; Srivastava S; McLeod DG; Vogel JC; Rhim JS
Exp Cell Res; 2008 Jan; 314(1):92-102. PubMed ID: 17900565
[TBL] [Abstract][Full Text] [Related]
16. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model.
Ding Z; Green AG; Yang X; Chernenko G; Tang SC; Pater A
Exp Cell Res; 2002 Jan; 272(2):185-91. PubMed ID: 11777343
[TBL] [Abstract][Full Text] [Related]
18. Growth of human nondiploid primary prostate tumor epithelial cells in vitro.
Chopra DP; Sarkar FH; Grignon DJ; Sakr WA; Mohamed A; Waghray A
Cancer Res; 1997 Sep; 57(17):3688-92. PubMed ID: 9288774
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of human benign prostate epithelial cells by high linear energy transfer alpha-particles.
Li H; Gu Y; Miki J; Hukku B; McLeod DG; Hei TK; Rhim JS
Int J Oncol; 2007 Sep; 31(3):537-44. PubMed ID: 17671680
[TBL] [Abstract][Full Text] [Related]
20. Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit.
Toouli CD; Huschtscha LI; Neumann AA; Noble JR; Colgin LM; Hukku B; Reddel RR
Oncogene; 2002 Jan; 21(1):128-39. PubMed ID: 11791183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
